Our Team

Morgan leads healthcare and life sciences investing for Breyer Capital. His work spans software, services, therapeutics, diagnostics, and AI. Prior to joining Breyer Capital, Morgan spent nearly a decade at Bessemer Venture Partners, where he helped lead the firm’s healthcare and life sciences investments and spearheaded early-stage investments in category-defining companies such as Abridge and Hinge Health. Morgan is also pursuing a fellowship in Clinical Genetics at Harvard/Boston Children’s. He serves as an Editorial Associate at NEJM AI and sits on the board of the Coalition for Health AI. His writing and research on clinical AI and genetic medicine have been published in leading biomedical journals such as Nature Medicine, NEJM AI, and PLOS. Morgan earned his B.S. in Computational Decision Sciences and M.D. from Brown University.

Daniel leads consumer investing for Breyer Capital. He led investments in portfolio companies like Headspace, Grammarly, Epic, Zumper, Citizen, and Stash. Before joining Breyer Capital, Daniel, with his brother Ted, co-founded Breyer Labs: a bootstrapped cryptocurrency fund. He also co-founded Flare (the one-stop shop for group communication) and invests in b2b opportunities focused on the future of work (ex Sana Benefits, Zen Business, Pryon). Daniel graduated magna cum laude from Brown University with a degree in History.

Samuel (Sam) J. Palmisano served as Chairman, President, and CEO of IBM from 2003 to 2011, remaining Chairman of the Board until September 2012, and Senior Adviser until his retirement in December 2012. Under his leadership, IBM delivered record financial results, transformed into a globally integrated enterprise, and launched its Smarter Planet initiative. Following his tenure at IBM, Sam became Chairman of the Center for Global Enterprise (CGE), a nonprofit, nonpartisan research institution focused on global business practices, management science, economic trends, and their societal impacts. He is also a frequent and sought-after co-investor alongside Breyer Capital.

Leo has 18 years of experience leading development and commercialization of advanced machine learning, AI, computer vision, diagnostic and digital health technologies that have made a significant impact on healthcare practice. As CEO of Paige, Leo led the company to become an industry leader, internationally launched several groundbreaking software products and became the first ever company to receive FDA approval for an AI product in pathology. Today, Leo is founder/CEO of Breyer Capital-backed Jona Health.